Stock Snapshot from
Cel-Sci CorpAdd to My Watchlist
CVM:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
- 0.21Last
- 0.02 -9.32%Today's Change
- 0.24Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | -0.040 |
| EPS: Year Est. 9/13 ttm | -0.040 |
| EPS: Quarterly Actual 3/13 | 0.00 |
| EPS: Quarterly Est. 6/13 | -0.02 |
| Price/Earnings ttm | -- |
| Relative Price/Earnings | -- |
| Earnings Growth Rate | 46.15 |
Company Description
| CEL-SCI Corporation researches and develops certain drugs and vaccines. The Company's Multikine is being tested to determine if it is effective in improving the immune response of cancer patients. CEL-SCI is also developing other products. The Company is currently targeting diseases such as AIDS, herpes simplex, malaria, tuberculosis, prostate cancer, and breast cancer. | |
| Revenue | $254,610 |
| Net Income | $-15 million |
| Total Assets | $16 million |
| Employees | 44 |
| Web Site | www.cel-sci.com |
Latest Headlines
No news available.
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.